Generali

Generali backs Italian stem cell trial

Italian insurer Generali and research organisation Associazione Revert Onlus have begun a three-year partnership to support cell therapy clinical trial on Amyotrophic Lateral Sclerosis.

Europe: Telematics around the world

"Black", "box" and "technology" have become buzzwords for the insurance industry, with firms of all stripes seeking to incorporate more data into both their underwriting and claims processes to give insurers a better idea of customer risks.

Generali boosts profits by 40%

Assicurazioni Generali has posted net profits of €1.6bn (£1.3m), a 40.4% increase on the nine month results last year.

RSA stock boosted by takeover rumours

Rumours of a buyout at RSA have seen the insurer’s share price climb 3.1p yesterday, reaching a high of £1.27 at the close of business on the London Stock Exchange.

Europe: Too big to fail?

The recent release of the Financial Stability Board's GSII list has led to complaints that insurers are not being differentiated from banks. Francesca Nyman explains.

Generali accepts G-SII designation

Italian insurer Generali has acknowledged its designation as a global systemically important insurer by the Financial Stability Board.

Generali accepts G-SII designation

Italian insurer Generali has acknowledged its designation as a global systemically important insurer by the Financial Stability Board.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here